Latest Leverage News

Knosys Limited is reshaping its future by focusing on its Libero library management platform, aiming to become a global leader through strategic simplification, AI innovation, and geographic expansion.

ReadCloud Limited reports a robust first half FY25 with 13% organic revenue growth and a 73% jump in underlying EBITDA, powered by its expanding VET-in-Schools segment and disciplined cost management.

ReadCloud Limited has reported a robust half-year performance with revenues up 13% and statutory profit soaring 214%, driven by significant growth in its Vocational Education & Training segment.

Uvre has cleared a crucial regulatory hurdle in its acquisition of New Zealand’s Waitekauri Gold Project, setting the stage for new leadership and exploration activities.

Clarity Pharmaceuticals has successfully imaged the first patient in its pivotal Phase III AMPLIFY trial for Cu-SAR-bisPSMA, a next-generation diagnostic agent targeting recurrent prostate cancer. This milestone sets the stage for potential FDA approval and broader clinical adoption.

BP8 has completed its inaugural shipment of Indonesian seaweed biomass to South Korean manufacturer MSC, Ltd., under a new sales cooperation agreement with PT Kebula Raya Bestari. This initial contract signals BP8’s growing footprint in the global seaweed supply chain.

Trigg Minerals has launched its maiden exploration program at the Antimony Canyon Project in Utah, aiming to unlock the potential of historically productive antimony mines with modern techniques.

Red Sky Energy has partnered with Condor Energy and associates to fund the drilling of the KN2 well at Killanoola, targeting a promising new reservoir zone identified by advanced seismic data. This move aims to boost production and accelerate cash flow from the South Australian oil project.

Xamble Group has acquired a 19% stake in Malaysia’s leading loyalty platform B Infinite, aiming to deepen influencer marketing engagement and unlock new revenue streams across Southeast Asia.

European Lithium Ltd and Critical Metals Corp have updated the Tanbreez Rare Earth Project scoping study, incorporating feldspar and arfvedsonite alongside eudialyte, underpinning a robust $2.4–3.0 billion NPV and a 162% IRR over a 19-year mine life.

Noxopharm has secured ethics approval to commence the HERACLES trial, marking the first human study of its novel SOF-SKN™ drug aimed at chronic inflammatory diseases.

St Barbara’s Concept Study confirms a 3 Mtpa processing hub in Nova Scotia, integrating Cochrane Hill with existing deposits to deliver stable, long-life gold production and strong economics while significantly reducing environmental impact.